Preliminary study of prevalence for bladder cancer in Isfahan Province, Iran

Objectives: To clarify period prevalence (PP), incidence rate (Ir), and reported mortality for patients with bladder cancer (BC) in Isfahan Province/Iran, as BC is the most common cancer of the urinary tract in Iran and other parts of the world. Patients and methods: Data from 21 March 2011 to 3 Mar...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hamid Mazdak, Zahra Tolou-Ghamari
Formato:	article
Lenguaje:	EN
Publicado:	Taylor & Francis Group 2018
Materias:	Bladder Cancer Incidence Prevalence Isfahan Diseases of the genitourinary system. Urology RC870-923
Acceso en línea:	https://doaj.org/article/7bc4596dd1e2413f890967c324caaeb9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:7bc4596dd1e2413f890967c324caaeb9
record_format	dspace
spelling	oai:doaj.org-article:7bc4596dd1e2413f890967c324caaeb92021-12-02T10:50:51ZPreliminary study of prevalence for bladder cancer in Isfahan Province, Iran2090-598X10.1016/j.aju.2017.11.017https://doaj.org/article/7bc4596dd1e2413f890967c324caaeb92018-06-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2090598X17301511https://doaj.org/toc/2090-598XObjectives: To clarify period prevalence (PP), incidence rate (Ir), and reported mortality for patients with bladder cancer (BC) in Isfahan Province/Iran, as BC is the most common cancer of the urinary tract in Iran and other parts of the world. Patients and methods: Data from 21 March 2011 to 3 March 2015 was obtained from the Isfahan Cancer Registry. BC was distinguished by the related established topography code (C67). Ir and PP were calculated and expressed per 100 000 persons. Results: In all, 279 females and 1376 males were identified. For the total population the PP was calculated as 33.2. This value corresponded to a PP of 54.4 for males and 11.4 for females (P < 0.001). Histologically, 63% of patients had invasive BC. Irs versus mortality rates were calculated for each year, i.e. 2011–2012, 2012–2013, 2013–2014, and 2014–2015, as 7.7 vs 0.56, 8.1 vs 0.74, 7.4 vs 0.98, and 9.9 vs 0.84, respectively. The mean (SD, range) age of the patients was 65.2 (13.9, 3–100) years. In relation to the age of the study population, BC occurred in 12% of patients aged <50 years and in 15% of those aged ≥80 years. Conclusion: The PP for BC in the male population was 4.8-times higher than females. There was a 28.6% increase in the Ir over the study period. Further study concerning environmental exposure, genetic factors, job-related exposure to various chemical carcinogens, and geographical distribution in Isfahan and its’ rural provinces would seem to be valuable.Hamid MazdakZahra Tolou-GhamariTaylor & Francis GrouparticleBladderCancerIncidencePrevalenceIsfahanDiseases of the genitourinary system. UrologyRC870-923ENArab Journal of Urology, Vol 16, Iss 2, Pp 206-210 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	Bladder Cancer Incidence Prevalence Isfahan Diseases of the genitourinary system. Urology RC870-923
spellingShingle	Bladder Cancer Incidence Prevalence Isfahan Diseases of the genitourinary system. Urology RC870-923 Hamid Mazdak Zahra Tolou-Ghamari Preliminary study of prevalence for bladder cancer in Isfahan Province, Iran
description	Objectives: To clarify period prevalence (PP), incidence rate (Ir), and reported mortality for patients with bladder cancer (BC) in Isfahan Province/Iran, as BC is the most common cancer of the urinary tract in Iran and other parts of the world. Patients and methods: Data from 21 March 2011 to 3 March 2015 was obtained from the Isfahan Cancer Registry. BC was distinguished by the related established topography code (C67). Ir and PP were calculated and expressed per 100 000 persons. Results: In all, 279 females and 1376 males were identified. For the total population the PP was calculated as 33.2. This value corresponded to a PP of 54.4 for males and 11.4 for females (P < 0.001). Histologically, 63% of patients had invasive BC. Irs versus mortality rates were calculated for each year, i.e. 2011–2012, 2012–2013, 2013–2014, and 2014–2015, as 7.7 vs 0.56, 8.1 vs 0.74, 7.4 vs 0.98, and 9.9 vs 0.84, respectively. The mean (SD, range) age of the patients was 65.2 (13.9, 3–100) years. In relation to the age of the study population, BC occurred in 12% of patients aged <50 years and in 15% of those aged ≥80 years. Conclusion: The PP for BC in the male population was 4.8-times higher than females. There was a 28.6% increase in the Ir over the study period. Further study concerning environmental exposure, genetic factors, job-related exposure to various chemical carcinogens, and geographical distribution in Isfahan and its’ rural provinces would seem to be valuable.
format	article
author	Hamid Mazdak Zahra Tolou-Ghamari
author_facet	Hamid Mazdak Zahra Tolou-Ghamari
author_sort	Hamid Mazdak
title	Preliminary study of prevalence for bladder cancer in Isfahan Province, Iran
title_short	Preliminary study of prevalence for bladder cancer in Isfahan Province, Iran
title_full	Preliminary study of prevalence for bladder cancer in Isfahan Province, Iran
title_fullStr	Preliminary study of prevalence for bladder cancer in Isfahan Province, Iran
title_full_unstemmed	Preliminary study of prevalence for bladder cancer in Isfahan Province, Iran
title_sort	preliminary study of prevalence for bladder cancer in isfahan province, iran
publisher	Taylor & Francis Group
publishDate	2018
url	https://doaj.org/article/7bc4596dd1e2413f890967c324caaeb9
work_keys_str_mv	AT hamidmazdak preliminarystudyofprevalenceforbladdercancerinisfahanprovinceiran AT zahratoloughamari preliminarystudyofprevalenceforbladdercancerinisfahanprovinceiran
_version_	1718396539919925248

Preliminary study of prevalence for bladder cancer in Isfahan Province, Iran

Ejemplares similares